COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 2269: Articles 22681-22690  | Next

The Effect of Early Hydroxychloroquine-based Therapy in COVID-19 Patients in Ambulatory Care Settings: A Nationwide Prospective Cohort Study
Sulaiman, T., Mohana, A., Alawdah, L., Mahmoud, N., Hassanein, M., Wani, T., Alfaifi, A., Alenazi, E., Radwan, N., AlKhalifah, N., Elkady, E., AlAnazi, M., Alqahtani, M., Abdalla, K., Yousif, Y., AboGazalah, F., Awwad, F., AlabdulKareem, K., AlGhofaili, F., AlJedai, A., Jokhdar, H., Alrabiah, F.
10.1101/2020.09.09.20184143 — Posted: 2020-09-13 Discussion: Onsite
Development of a serological assay to identify SARS-CoV-2 antibodies in COVID-19 patients
Huynh, A., Arnold, D. M., Kelton, J. G., Smith, J. W., Moore, J. C., Chetty, V. T., Stacey, H. D., Ang, J. C., Chagla, Z., Harvey, B. J., Bowdish, D. M., Miller, M. S., Nazy, I.
10.1101/2020.09.11.20192690 — Posted: 2020-09-13
Shedding of infectious SARS-CoV-2 from airways in hospitalized COVID-19 patients in relation to serum antibody responses
Glans, H., Gredmark-Russ, S., Olausson, M., Falck-Jones, S., Varnaite, R., Christ, W., Maleki, K. T., Lind Karlberg, M., Broddesson, S., Falck-Jones, R., Bell, M., Johansson, N., Farnert, A., Smed Sorensen, A., Klingstrom, J., Brave, A.
10.1101/2020.09.11.20191940 — Posted: 2020-09-13
RAAS blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis
Kaur, U., Chakrabarti, S. S., Patel, T. K.
10.1101/2020.09.09.20191445 — Posted: 2020-09-13
Seroprevalence and Correlates of SARS-CoV-2 Antibodies in Healthcare Workers in Chicago
Wilkins, J., Gray, E. L., Wallia, A., Hirschhorn, L., Zembower, T., Ho, J., Kalume, N., Agbo, O., Zhu, A., Rasmussen-Torvic, L., Khan, S., Carnethon, M., Huffman, M., Evans, C.
10.1101/2020.09.11.20192385 — Posted: 2020-09-13
The major predictors of testing positive for COVID-19 among symptomatic hospitalized patients
barasa, s.
10.1101/2020.09.11.20192963 — Posted: 2020-09-13
Taste alteration in COVID-19: a rapid review with data synthesis reveals significant geographical differences
Cirillo, N.
10.1101/2020.09.11.20192831 — Posted: 2020-09-13
S494 O-glycosylation site on the SARS-COV-2 RBD Affects the Virus Affinity to ACE2 and its Infectivity; A Molecular Dynamics Study
Rahnama, S., Azimzadeh Irani, M., Amininasab, M., Ejtehadi, R.
10.1101/2020.09.12.294504 — Posted: 2020-09-12
A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2
Zhang, Y., Song, W., Chen, S., Yuan, Z., Yi, Z.
10.1101/2020.09.11.294330 — Posted: 2020-09-12
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
Gao, D., Li, F., Han, M., Dai, P., Xu, W., He, J., Tao, X., Wu, Y., Tong, X., Xia, X., Guo, W., Li, Y., Zhu, Y., Zhang, X., Liu, Z., Aji, R., Cai, X., Li, Y., Qu, D., Chen, Y., Jiang, S., Wang, Q., Ji, H., Xie, Y., Sun, Y., Lu, L., Zhou, Y.
10.1101/2020.09.11.293035 — Posted: 2020-09-12 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).